DK3283110T3 - Antistoffer rettet mod interleukin-36-receptor (il-36r) - Google Patents
Antistoffer rettet mod interleukin-36-receptor (il-36r) Download PDFInfo
- Publication number
- DK3283110T3 DK3283110T3 DK16780800.5T DK16780800T DK3283110T3 DK 3283110 T3 DK3283110 T3 DK 3283110T3 DK 16780800 T DK16780800 T DK 16780800T DK 3283110 T3 DK3283110 T3 DK 3283110T3
- Authority
- DK
- Denmark
- Prior art keywords
- interleukin
- antibodies
- receptor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/33—Crossreactivity, e.g. for species or epitope, or lack of said crossreactivity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pain & Pain Management (AREA)
- Transplantation (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Dermatology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562147824P | 2015-04-15 | 2015-04-15 | |
| PCT/US2016/027676 WO2016168542A1 (en) | 2015-04-15 | 2016-04-15 | Antibodies directed against interleukin 36 receptor (il-36r) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3283110T3 true DK3283110T3 (da) | 2022-05-23 |
Family
ID=57126337
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK16780800.5T DK3283110T3 (da) | 2015-04-15 | 2016-04-15 | Antistoffer rettet mod interleukin-36-receptor (il-36r) |
Country Status (14)
| Country | Link |
|---|---|
| US (4) | US10526410B2 (da) |
| EP (2) | EP3283110B1 (da) |
| JP (4) | JP6913026B2 (da) |
| KR (1) | KR102666920B1 (da) |
| CN (2) | CN107847590B (da) |
| AU (1) | AU2016248208B2 (da) |
| CA (1) | CA2982555A1 (da) |
| DK (1) | DK3283110T3 (da) |
| ES (1) | ES2914243T3 (da) |
| MX (2) | MX2017013080A (da) |
| PL (1) | PL3283110T3 (da) |
| RU (1) | RU2745898C2 (da) |
| SG (1) | SG11201708061TA (da) |
| WO (1) | WO2016168542A1 (da) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI2780373T1 (sl) | 2011-11-16 | 2019-12-31 | Boehringer Ingelheim International Gmbh | Protitelesa proti IL-36R |
| SG11201708061TA (en) * | 2015-04-15 | 2017-10-30 | Anaptysbio Inc | Antibodies directed against interleukin 36 receptor (il-36r) |
| JP2020512344A (ja) * | 2017-03-27 | 2020-04-23 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 抗ｉｌ−３６ｒ抗体併用治療 |
| EP3400962A1 (en) * | 2017-05-09 | 2018-11-14 | Fraunhofer Gesellschaft zur Förderung der angewandten Forschung e.V. | Inhibitors of il-38 for use in treating and/or preventing cancer in a subject |
| CA3070446A1 (en) | 2017-07-25 | 2019-01-31 | Immutics, Inc. | Treating cancer by blocking the interaction of tim-3 and its ligand |
| JP7404256B2 (ja) * | 2018-03-14 | 2023-12-25 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 汎発性膿疱性乾癬の処置のための抗ｉｌ－３６ｒ抗体の使用 |
| BR112020016401A2 (pt) * | 2018-03-14 | 2020-12-15 | Boehringer Ingelheim International Gmbh | Uso de anticorpos anti-il-36r para o tratamento de doença inflamatória intestinal |
| AU2019306217B2 (en) * | 2018-07-16 | 2024-01-25 | Regeneron Pharmaceuticals, Inc. | Anti-IL36R antibodies |
| RS65759B1 (sr) * | 2018-07-16 | 2024-08-30 | Regeneron Pharma | Modeli glodara za ditra oboljenje i njihova upotreba |
| CN110818796B (zh) * | 2018-08-09 | 2022-11-08 | 东莞市朋志生物科技有限公司 | 一种抗人ca153蛋白的重组抗体 |
| EP3898673A1 (en) | 2018-12-21 | 2021-10-27 | 23Andme, Inc. | Anti-il-36 antibodies and methods of use thereof |
| MX2021007807A (es) * | 2018-12-27 | 2021-08-11 | Boehringer Ingelheim Int | Anticuerpos anti-il-36r para el tratamiento de pustulosis palmoplantar. |
| WO2020160156A2 (en) | 2019-01-30 | 2020-08-06 | Immutics, Inc. | Anti-gal3 antibodies and uses thereof |
| IL286100B2 (en) * | 2019-03-08 | 2024-12-01 | Boehringer Ingelheim Int | Anti-il-36r antibody formulations |
| CA3147020A1 (en) * | 2019-08-07 | 2021-02-11 | Joe G.N. Garcia | Anti-nampt antibodies and uses thereof |
| WO2021112196A1 (ja) * | 2019-12-05 | 2021-06-10 | 学校法人東京薬科大学 | 筋組織の減少を抑制するための組成物 |
| AR120913A1 (es) * | 2019-12-27 | 2022-03-30 | Teijin Pharma Ltd | Anticuerpo que inhibe específicamente la señalización de il-36r |
| KR20230016186A (ko) | 2020-05-26 | 2023-02-01 | 트루바인딩 아이엔씨. | 갈렉틱-3 차단에 의한 염증성 질환의 치료 방법 |
| CN116745315A (zh) | 2020-07-17 | 2023-09-12 | 勃林格殷格翰国际有限公司 | 用于治疗嗜中性皮肤病的抗il-36r抗体 |
| WO2022026829A1 (en) | 2020-07-30 | 2022-02-03 | Anaptysbio, Inc. | Anti-interleukin 36 receptor (il-36r) therapy for skin toxicity |
| CN116406295A (zh) * | 2020-07-30 | 2023-07-07 | 安奈普泰斯生物有限公司 | 针对鱼鳞病的抗白介素36受体（il-36r）疗法 |
| CN112094349B (zh) * | 2020-11-04 | 2021-02-09 | 上海华奥泰生物药业股份有限公司 | 靶向于白介素36r的抗体及其制备方法和应用 |
| WO2022150644A1 (en) | 2021-01-08 | 2022-07-14 | Anaptysbio, Inc. | Anti-interleukin 36 receptor (il-36r) therapy for acne |
| WO2022150642A1 (en) | 2021-01-08 | 2022-07-14 | Anaptysbio, Inc. | Anti-interleukin 36 receptor (il-36r) therapy for hidradenitis suppurativa |
| TW202302644A (zh) * | 2021-03-04 | 2023-01-16 | 德商百靈佳殷格翰國際股份有限公司 | 治療gpp之方法 |
| JP2024512384A (ja) | 2021-03-12 | 2024-03-19 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 汎発型膿疱性乾癬における抗ｉｌ－３６ｒ抗体による処置に関連したバイオマーカー |
| JP2024518536A (ja) * | 2021-05-12 | 2024-05-01 | アナプティスバイオ インコーポレイティッド | 抗体組成物 |
| WO2023285362A1 (en) | 2021-07-12 | 2023-01-19 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Use of il-36 inhibitors for the treatment of netherton syndrome |
| TW202323293A (zh) * | 2021-10-29 | 2023-06-16 | 新加坡商創響私人有限公司 | 新型抗ｉｌ－３６ｒ抗體 |
| CN115724975A (zh) * | 2022-10-20 | 2023-03-03 | 江苏荃信生物医药股份有限公司 | 抗人白介素36受体单克隆抗体及其应用 |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4828981A (en) | 1983-08-24 | 1989-05-09 | Synbiotics Corporation | Immunoassays for determining Dirofilaria immitis infection using antiidiotype monoclonal antibody reagents |
| GB8601597D0 (en) | 1986-01-23 | 1986-02-26 | Wilson R H | Nucleotide sequences |
| EP0557459B1 (en) | 1990-11-13 | 1997-10-22 | Immunex Corporation | Bifunctional selectable fusion genes |
| CA2163427A1 (en) | 1993-05-21 | 1994-12-08 | Stephen D. Lupton | Bifunctional selectable fusion genes based on the cytosine deaminase (cd) gene |
| US5814618A (en) | 1993-06-14 | 1998-09-29 | Basf Aktiengesellschaft | Methods for regulating gene expression |
| US5464758A (en) | 1993-06-14 | 1995-11-07 | Gossen; Manfred | Tight control of gene expression in eucaryotic cells by tetracycline-responsive promoters |
| US5595756A (en) * | 1993-12-22 | 1997-01-21 | Inex Pharmaceuticals Corporation | Liposomal compositions for enhanced retention of bioactive agents |
| WO2001057219A2 (en) | 2000-02-02 | 2001-08-09 | Schering Corporation | Mammalian interleukin-1-delta and -epsilon. their use in therapeutic and diagnostic methods |
| FR2814642B1 (fr) | 2000-10-03 | 2005-07-01 | Ass Pour Le Dev De La Rech En | Souris transgenique pour la recombinaison ciblee mediee par la cre-er modifiee |
| DE60226641D1 (de) | 2001-12-03 | 2008-06-26 | Amgen Fremont Inc | Antikörperkategorisierung auf der grundlage von bindungseigenschaften |
| US8034771B2 (en) | 2006-09-08 | 2011-10-11 | Amgen Inc. | IL-1F6 polypeptides |
| WO2008103474A1 (en) | 2007-02-20 | 2008-08-28 | Anaptysbio, Inc. | Methods of generating libraries and uses thereof |
| EP2337799A2 (en) | 2008-08-28 | 2011-06-29 | Wyeth LLC | Uses of il-22, il-17, and il-1 family cytokines in autoimmune diseases |
| US20140234330A1 (en) * | 2011-07-22 | 2014-08-21 | Amgen Inc. | Il-17 receptor a is required for il-17c biology |
| SI2780373T1 (sl) | 2011-11-16 | 2019-12-31 | Boehringer Ingelheim International Gmbh | Protitelesa proti IL-36R |
| EP2797951B1 (en) | 2011-12-28 | 2018-01-31 | ImmunoQure AG | Method of isolating human antibodies |
| US9409977B2 (en) * | 2013-03-12 | 2016-08-09 | Decimmune Therapeutics, Inc. | Humanized, anti-N2 antibodies |
| SG11201708061TA (en) * | 2015-04-15 | 2017-10-30 | Anaptysbio Inc | Antibodies directed against interleukin 36 receptor (il-36r) |
| JP2020512344A (ja) | 2017-03-27 | 2020-04-23 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 抗ｉｌ−３６ｒ抗体併用治療 |
| BR112020016401A2 (pt) | 2018-03-14 | 2020-12-15 | Boehringer Ingelheim International Gmbh | Uso de anticorpos anti-il-36r para o tratamento de doença inflamatória intestinal |
| JP7404256B2 (ja) | 2018-03-14 | 2023-12-25 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 汎発性膿疱性乾癬の処置のための抗ｉｌ－３６ｒ抗体の使用 |
| AU2019306217B2 (en) | 2018-07-16 | 2024-01-25 | Regeneron Pharmaceuticals, Inc. | Anti-IL36R antibodies |
| EP3898673A1 (en) | 2018-12-21 | 2021-10-27 | 23Andme, Inc. | Anti-il-36 antibodies and methods of use thereof |
| MX2021007807A (es) | 2018-12-27 | 2021-08-11 | Boehringer Ingelheim Int | Anticuerpos anti-il-36r para el tratamiento de pustulosis palmoplantar. |
| IL286100B2 (en) | 2019-03-08 | 2024-12-01 | Boehringer Ingelheim Int | Anti-il-36r antibody formulations |
| EP3974445A4 (en) | 2019-05-20 | 2023-03-22 | Nantong Yichen Biopharma. Co. Ltd. | BISPECIFIC MOLECULE, ITS MANUFACTURE AND USE |
-
2016
- 2016-04-15 SG SG11201708061TA patent/SG11201708061TA/en unknown
- 2016-04-15 JP JP2017553885A patent/JP6913026B2/ja active Active
- 2016-04-15 CN CN201680034793.6A patent/CN107847590B/zh active Active
- 2016-04-15 WO PCT/US2016/027676 patent/WO2016168542A1/en not_active Ceased
- 2016-04-15 CN CN202210803364.8A patent/CN115925932A/zh active Pending
- 2016-04-15 EP EP16780800.5A patent/EP3283110B1/en active Active
- 2016-04-15 KR KR1020177032985A patent/KR102666920B1/ko active Active
- 2016-04-15 DK DK16780800.5T patent/DK3283110T3/da active
- 2016-04-15 RU RU2017139481A patent/RU2745898C2/ru active
- 2016-04-15 CA CA2982555A patent/CA2982555A1/en active Pending
- 2016-04-15 EP EP22162381.2A patent/EP4176900A1/en active Pending
- 2016-04-15 AU AU2016248208A patent/AU2016248208B2/en active Active
- 2016-04-15 US US15/567,045 patent/US10526410B2/en active Active
- 2016-04-15 MX MX2017013080A patent/MX2017013080A/es unknown
- 2016-04-15 ES ES16780800T patent/ES2914243T3/es active Active
- 2016-04-15 PL PL16780800T patent/PL3283110T3/pl unknown
-
2017
- 2017-10-11 MX MX2023001791A patent/MX2023001791A/es unknown
-
2019
- 2019-11-18 US US16/686,373 patent/US11130814B2/en active Active
-
2021
- 2021-04-15 JP JP2021069306A patent/JP7212098B2/ja active Active
- 2021-08-26 US US17/412,737 patent/US12391761B2/en active Active
-
2023
- 2023-01-12 JP JP2023003385A patent/JP7721585B2/ja active Active
-
2025
- 2025-07-24 US US19/279,706 patent/US20260022181A1/en active Pending
- 2025-07-30 JP JP2025127775A patent/JP2025163120A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3283110T3 (da) | Antistoffer rettet mod interleukin-36-receptor (il-36r) | |
| IL272227A (en) | Anti-tigit antibodies | |
| IL269405A (en) | Anti-sirp alpha antibodies | |
| DK3625259T3 (da) | Anti-sirpalpha-antistoffer | |
| PT3606954T (pt) | Anticorpos anti-lag3 | |
| EP3661558A4 (en) | ANTI-IL1RAP ANTIBODIES | |
| CL2018000370A1 (es) | Nuevos anticuerpos anti-pd-1 | |
| EP3569709A4 (en) | ANTI-GPC3 ANTIBODIES | |
| CL2018000281A1 (es) | Anticuerpos monoclonales contra bcma | |
| DK3344654T3 (da) | Anti-lag-3-antistoffer | |
| HUE047929T2 (hu) | Kiméra antigén receptor | |
| IL251963A0 (en) | Anti-pd-1 antibodies | |
| DK3350218T5 (da) | Polyomavirus-neutraliserende antistoffer | |
| HUE060878T2 (hu) | Anti-transztiretin antitestek | |
| DK3250593T3 (da) | Anti-transthyretin-antistoffer | |
| EP3691447A4 (en) | ANTI-TRANSTHYRETINE ANTIBODY | |
| EP3684806A4 (en) | NEW ANTI-CD3EPSILON ANTIBODIES | |
| DK3606961T3 (da) | Garp-tgf-beta-antistoffer | |
| IL256099A (en) | Antibody | |
| PL3215530T3 (pl) | Ulepszone przeciwciała anty-il-6 | |
| IL257368A (en) | Antibody | |
| DK3484921T3 (da) | Anti-IL-22R antistoffer | |
| DK3452515T3 (da) | Her-2-bindende antistoffer | |
| HUE054148T2 (hu) | Anti-ORAI1 antitest | |
| DK3126391T3 (da) | ANTISTOFFER MOD HPA-1a |